Champions Oncology Inc Stock
Your prediction
Champions Oncology Inc Stock
There is an upward development for Champions Oncology Inc compared to yesterday, with an increase of €0.15 (2.560%).
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | 2.560% | 7.143% | -4.762% | -31.818% | 3.448% | 53.061% | -34.066% |
| Ardelyx Inc. | -3.030% | -12.646% | 13.772% | 15.995% | 18.404% | 100.586% | 1.785% |
| Evolus Inc | -0.470% | -12.863% | -28.205% | -58.000% | -22.936% | -46.154% | -12.244% |
| ImmunityBio Inc. | 40.150% | 137.319% | 158.437% | 61.130% | 172.717% | 8.005% | -66.646% |
News
3 Dividend Champions to Buy and Hold for Decades
There's a saying on Wall Street that "dividends don't lie." Just about every financial metric can be spun by a company's management, but dividends either arrive in the mail or they don't. Companies
3 Dividend Champion Stocks I'm Watching in 2025
If you are looking for high-yield stocks in a stock market that is hovering near all-time highs, a good place to start your search is with reliable dividend payers.
Dividend Champions fit the bill